SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001023024-06-000011
Filing Date
2006-04-28
Accepted
2006-04-28 15:22:43
Documents
6
Period of Report
2006-04-28
Effectiveness Date
2006-04-28

Document Format Files

Seq Description Document Type Size
1 BIOSANTE PHARMACEUTICALS 2006 PROXY STATEMENT biosante2006proxy.htm DEF 14A 745179
2 BIOSANTE LOGO biosantelogo6.jpg GRAPHIC 10177
3 GRAPH FOR PROXY graph1.jpg GRAPHIC 32179
5 OPPENHEIMER LOGO opplogo.jpg GRAPHIC 7936
6 PROXY CARD 2006 proxycard2.jpg GRAPHIC 180011
7 PROXYCARD PAGE 2 2006 proxycard2page2.jpg GRAPHIC 49714
  Complete submission text file 0001023024-06-000011.txt   1133316
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 06789627
SIC: 2836 Biological Products, (No Diagnostic Substances)